Skip to content
Bored Studies
RecruitingPhase 3

Randomized Withdrawal Study in Patients With Schizophrenia

Vanda Pharmaceuticals · NCT06961968

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–65 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 3
Target enrollment
400
US sites recruiting
22
Study start
May 14, 2025
Record last updated
January 12, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.

Being studied: iloperidone; placebo

Conditions: Schizophrenia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Males or females 18 to 65 years of age (inclusive)
  • Diagnosed with schizophrenia per DSM-5 criteria
  • In need of ongoing psychiatric treatment

Exclusion Criteria

  • DSM-5 diagnosis of a psychiatric disorder other than schizophrenia that was the primary focus of treatment within the previous six months

Recruiting US locations

  • Vanda Investigational Site

    Rogers, AR 72758

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Costa Mesa, CA 92626

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Lemon Grove, CA 91945

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Oceanside, CA 92056

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Pico Rivera, CA 90660

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    San Diego, CA 92123

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Walnut Creek, CA 94596

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    North Miami, FL 33161

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Atlanta, GA 30328

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Peachtree Corners, GA 30071

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Chicago, IL 60641

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Flowood, MS 39232

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Saint Charles, MO 63304

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    St Louis, MO 63141

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Las Vegas, NV 89119

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Marlton, NJ 08053

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Staten Island, NY 10314

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Austin, TX 78754

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Houston, TX 77081

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Irving, TX 75062

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Richardson, TX 75080

    Site contact: Vanda Pharmaceuticals · 202-734-3400

  • Vanda Investigational Site

    Bellevue, WA 98007

    Site contact: Vanda Pharmaceuticals · 202-734-3400

Study contacts (from the official record)

  • Vanda Pharmaceuticals Inc. · 202-734-3400 · clinicaltrials@vandapharma.com
All mental health studies in Arkansas →
Randomized Withdrawal Study in Patients With Schizophrenia (NCT06961968) | Bored Studies